Osaka, Japan

Chiaki Takeda

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ishihara Sangyo Kaisha, Ltd.. Active years: 2021.


% Patents Active = 100.0



Average Co-Inventor Count = 2.7

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chiaki Takeda: Innovator in Pesticidal Compositions

Introduction

Chiaki Takeda is a notable inventor based in Osaka, Japan. She has made significant contributions to the field of pest control through her innovative pesticidal compositions. With a total of 2 patents, her work focuses on developing effective solutions for pest management.

Latest Patents

Chiaki Takeda's latest patents include a pesticidal composition and a method for controlling pests. This composition combines flonicamid and D-limonene as active ingredients, with a mixing weight ratio ranging from 1:150 to 1:1. The aim is to provide a highly effective solution for pest control. Additionally, she has developed a pesticidal solid composition containing cyclaniliprole or its salt. This composition is designed to enhance controlling effects while reducing labor in application operations with a smaller dose.

Career Highlights

Chiaki Takeda is currently employed at Ishihara Sangyo Kaisha, Ltd. Her work at this company has allowed her to focus on creating innovative solutions in the agricultural sector. Her contributions have been recognized for their potential to improve pest control methods significantly.

Collaborations

Chiaki has collaborated with notable coworkers, including Mitsugu Iwasa and Mitsuo Sano. These collaborations have fostered a creative environment that encourages the development of new ideas and solutions in pest management.

Conclusion

Chiaki Takeda's innovative work in pesticidal compositions showcases her dedication to improving pest control methods. Her patents reflect her commitment to creating effective and efficient solutions in agriculture.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…